Gilead Sciences, Inc.: Drug Recall
Recall #D-0299-2022 · 12/03/2021
Class I: Dangerous
Recall Details
- Recall Number
- D-0299-2022
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- Gilead Sciences, Inc.
- Status
- Terminated
- Date Initiated
- 12/03/2021
- Location
- Foster City, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 53,473 vials
Reason for Recall
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
Product Description
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Distribution Pattern
Nationwide in the USA
Other Recalls by Gilead Sciences, Inc.
- Class I: Dangerous 09/19/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.